BRM undiluted NAV as at 31/1/17 – $0.6333

BRM undiluted NAV as at 31/1/17 - $0.6333
Date31/1/201725/1/2017
BRM undiluted NAV*$0.6333$0.6465
Share price close$0.64 $0.63
Premium / Discount-1%3%
The five largest portfolio holdings at 31 January 2017 are approximately as follows:
CSL Limited6%
SEEK 5%
Ramsay Health Care5%
ResMed5%
National Australia Bank5%
BACKGROUND
For further information please contact Barramundi Ltd, ph (09) 489 7074.
BarramundiisalistedinvestmentcompanythatinvestsingrowingAustraliancompanies.TheBarramundiportfolioismanagedby
FisherFunds,aspecialistinvestmentmanagerwithatrackrecordofsuccessfullyinvestingingrowthcompanyshares.Theaimof
Barramundiistoofferinvestorscompetitivereturnsthroughcapitalgrowthanddividends,andaccesstoadiversifiedportfolioof
investmentsthroughasingletax-efficientinvestmentvehicle.BarramundilistedontheNZXMainBoardon26October2006and
may invest in companies that are listed on an Australian stock exchange or unlisted companies.
The NAV per share is calculated after deducting treasury stock (shares acquired under the Barramundi buyback programme) -
currently nil.
* The undiluted NAV excludes any impact on the NAV of the future exercise of warrants (BRMWD). At 31 January 2017,
36,471,368 warrants are on issue and may be exercised on 24 November 2017. The actual exercise price of each warrant is $0.63
less the dividends per share declared by the company between 21 November 2016 and 24 November 2017. Dividends totalling
1.39 cents per share have been declared to date and three more dividends are expected to be declared in the remaining period to
24 November 2017.
The above net asset value (NAV) is unaudited and net of fees and tax.


Barramundi Limited
Phone +64 9 489 7074
Fax +64 9 489 7139
Private Bag 93502
Takapuna, Auckland